Dr. Steven W. Pipe, MD

Dr. Pipe practices at University Hospital in Ann Arbor, Michigan.

Dr. Pipe's NPI, 1255341889, was assigned on August 8, 2006. Dr. Pipe holds Michigan license 4301061199.

Dr. Pipe's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Dr. Pipe's primary practice is University Hospital in Ann Arbor, Michigan. Dr. Pipe is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dr. Pipe's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Pipe practices, 2 sites in all. Vendor and product names are available with a free account.

Pediatric hematology-oncology is Dr. Pipe's primary specialty in the NPI Registry, under taxonomy code 2080P0207X. Dr. Pipe is licensed in Michigan.

CMS data shows 89 Medicare services from Dr. Pipe across 1 procedure code in 2024, for 78 Medicare patients. Medicare paid $2,357 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. Pipe in 2024. The largest group is 65 to 74, with 34 patients. 74% of them have high blood pressure, and 64% have high cholesterol. 38% are also on Medicaid. Their average risk score is 2.69, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Pipe's median patient age at 25, with 72% women.

In 2023, Dr. Pipe wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $571 in total drug cost. In 2020, CMS named 14 claims across 1 drug.

Dr. Pipe accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 124 papers to Dr. Pipe, published from 2010 to 2025. 2024 was the busiest year, with 17. The most frequent topics are Hemophilia A, Factor VIII and Genetic Therapy. Dr. Pipe has published most often in Haemophilia. Dr. Pipe's most frequent co-authors are Guy Aaron Young, MD, Alok K. Srivastava, MD and Craig Kessler.

Dmand AI links Dr. Pipe to 5 clinical trials. Conditions studied include Hemophilia A, Hemophilia B and Coagulation Protein Disorders. Genzyme, a Sanofi Company sponsors the most, 3. Open Payments lists research payments to Dr. Pipe that name 5 trials.

CMS Open Payments shows 972 general payments to Dr. Pipe from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 50% of the total. CSL Behring paid the most, $267,847. It also lists 78 research payments totaling $104,077 from 2017 to 2025, naming 5 clinical trials.